Holiday Notification: Cayman Chemical will be closed Monday, May 28, 2012, in observance of the Memorial Day holiday.
More…
Please feel free to continue placing orders via our website or via fax at 734-971-3640. You may send an email to customer service at custserv@caymanchem.com , or to technical support at techserv@caymanchem.com which we will respond to the next business day. Cayman will resume regular business hours and shipping schedules on Tuesday, May 29, 2012. Thank you for your patience and understanding.
Plerixafor (hydrochloride hydrate)
Cayman Chemical Item Number 10011332
Mobozil™; SID 791; JM 3100; AMD 3100
(CAS 155148-31-5)
The α-chemokine receptor, CXCR4, on CD4+ T-cells is used by CXCR4-selective HIV forms as a gateway for T-cell infection. In mammalian cell signaling, CXCR4 activation promotes the homing of hematopoietic stem cells, chemotaxis and quiescence of lymphocytes, and growth and metastasis of certain cancer cell types. Plerixafor (hydrochloride) is a macrocyclic compound that acts as an irreversible antagonist against the binding of CXCR4 with its ligand, SDF-1 (CXCL12). It suppresses infection by HIV with an IC50 value of 1-10 ng/ml1 with selectivity toward CXCR4-tropic virus.2 Plerixafor mobilizes hematopoietic stem and progenitor cells for transplant3 better than the 'gold standard', G-CSF alone 4 and synergizes with G-CSF.3 It also increases T-cell trafficking in the blood and spleen5 as well as the central nervous system.6 Plerixafor regulates the growth of primary and metastic breast cancer cells7 and inhibits dissemination of ovarian carcinoma cells.8
1
De Clercq, E., Yamamoto, N., Pauwels, R., et al. Highly potent and selective inhibition of human immunodeficiency virus by the bicyclam derivative JM3100. Antimicrob Agents Chemother38(4)668-674(1994).
2
Fransen, S., Bridger, G., Whitcomb, J.M., et al. Supression of dualtropic human immunodeficiency virus type 1 by the CXCR4 antagonist AMD3100 is associated with efficiency of CXCR4 use and baseline virus composition. Antimicrob Agents Chemother52(7)2608-2615(2008).
3
Broxmeyer, H.E., Orschell, C.M., Clapp, D.W., et al. Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist. J Exp Med201(8)1307-1318(2005).
4
Hess, D.A., Bonde, J., Craft, T.C., et al. Human progenitor cells rapidly mobilized by AMD3100 repopulate NOD/SCID mice with increased frequency in comparison to cells from the same donor mobilized by granulocyte colony stimulating factor. Biol Blood Marrow Transplant13398-411(2007).
5
Bernardini, G., Sciumè, G., Bosisio, D., et al. CCL3 and CXCL12 regulate trafficking of mouse bone marrow NK cell subsets. Blood111(7)3626-3634(2008).
6
McCandless, E.E., Zhang, B., Diamond, M.S., et al. CXCR4 antagonism increases T cell trafficking in the central nervous system and improves survival from west nile virus encephalitis. Proc Natl Acad Sci USA105(32)11270-11275(2008).
7
Smith, M.C.P., Luker, K.E., Garbow, J.R., et al. CXCR4 regulates growth of both primary and metastatic breast cancer. Cancer Res648604-8612(2004).
8
Kajiyama, H., Shibata, K., Terauchi, M., et al. Involvement of SDF-1a/CXCR4 axis in the enhanced peritoneal metastasis of epithelial ovarian carcinoma. Int J Cancer12291-99(2008).
Room temperature
in continental US; may vary elsewhere
SMILES
Copy SMILES to clipboard
N1CCCNCCN(CCCNCC1)Cc1ccc(cc1)CN1CCCNCCNCCCNCC1
Background Reading
De Clercq, E., Yamamoto, N., Pauwels, R., et al. Highly potent and selective inhibition of human immunodeficiency virus by the bicyclam derivative JM3100. Antimicrob Agents Chemother38(4)668-674(1994).
Fransen, S., Bridger, G., Whitcomb, J.M., et al. Supression of dualtropic human immunodeficiency virus type 1 by the CXCR4 antagonist AMD3100 is associated with efficiency of CXCR4 use and baseline virus composition. Antimicrob Agents Chemother52(7)2608-2615(2008).
Broxmeyer, H.E., Orschell, C.M., Clapp, D.W., et al. Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist. J Exp Med201(8)1307-1318(2005).
Hess, D.A., Bonde, J., Craft, T.C., et al. Human progenitor cells rapidly mobilized by AMD3100 repopulate NOD/SCID mice with increased frequency in comparison to cells from the same donor mobilized by granulocyte colony stimulating factor. Biol Blood Marrow Transplant13398-411(2007).
Bernardini, G., Sciumè, G., Bosisio, D., et al. CCL3 and CXCL12 regulate trafficking of mouse bone marrow NK cell subsets. Blood111(7)3626-3634(2008).
McCandless, E.E., Zhang, B., Diamond, M.S., et al. CXCR4 antagonism increases T cell trafficking in the central nervous system and improves survival from west nile virus encephalitis. Proc Natl Acad Sci USA105(32)11270-11275(2008).
Smith, M.C.P., Luker, K.E., Garbow, J.R., et al. CXCR4 regulates growth of both primary and metastatic breast cancer. Cancer Res648604-8612(2004).
Kajiyama, H., Shibata, K., Terauchi, M., et al. Involvement of SDF-1a/CXCR4 axis in the enhanced peritoneal metastasis of epithelial ovarian carcinoma. Int J Cancer12291-99(2008).